One of the buyers, AstraZeneca, said separately that it would divest several hypertension drugs as it shifts the focus of…More
The mission of Make-A-Wish is to create life-changing wishes for children with critical illnesses, so joining together with Genentech was…More
In an interview on CNBC’s “Squawk Box,” Paul Stoffels, the drugmaker’s chief scientific officer, said the company had started working…More
uLab Systems, headquartered in San Francisco, raised $18 million for its software, which lets orthodontists create aligners for patients on…More
The various stakeholders need to collaborate to design and configure technology that not only meets regulatory, payer, and organizational needs…More
The two health insurance companies signaled that they had met all regulatory requirements for the merger, including review by the…More
Proteus, which makes tiny sensors that can track medication adherence, will no longer develop the technology in behavioral health medications…More
The drug, Tepezza, is described as the first-ever drug treatment for thyroid eye disease, a debilitating disease usually treated with…More
The agency gave accelerated approval to Tazverik in epithelioid sarcoma, a rare but serious connective tissue cancer. The company is…More
Although they’ve seen growth in the last few years, full implementation of outcome-based contracts faces hurdles like expensive technology, outmoded…More
